Browse Items (18 total)

• 

  After the Ebola Outbreak: Lessons Learned

  Tags Critical Care, Ebola, Experimental Drugs, Follow up, Infection Prevention and Control, Nursing, Patient Care, Personal Protective Equipment (PPE), Prophylaxis, R-PPE, R-T&E, Survivors, Therapeutics, Training, Translational Research
  Creator: Loftus, Mary (editor), Emory Medicine
  Subject: General
  Item Type: Hyperlink
  Date Last Updated: 2018-02-20
  Description: In the wake of caring for four patients with active Ebola virus in 2014, Emory clinicians have taken stock of lessons learned in infectious disease prevention, therapeutic care, and health aftereffects and are sharing that information broadly with…

• Are We Ready for the Next Outbreak?

  Tags Ebola, Epidemic, Epidemiology, Experimental Drugs, Federal, International Response, Medical Surveillance, Outbreaks, Pandemic, Prophylaxis, Public Health, R-Gen
  Creator: U.S. Agency for International Development
  Subject: General
  Item Type: Webinar
  Date Last Updated: 2018-04-01
  Description: A three part pod-cast series discusses the need for new and improved tools to fight infectious disease, as demonstrated by the recent outbreaks of Ebola and Zika.

• Building a National Capability to Monitor and Assess Medical Countermeasure Use During a Public Health Emergency: Going Beyond the Last Mile: Proceedings of a Workshop

  Tags Ethics, Federal Research Partners, Informed Consent, Institutional Review Board (IRB), Patient Care, Prophylaxis, Public Health, R-Res&Pub, Therapeutics, Vaccine Study
  Creator: National Academies of Sciences, E. and Medicine
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2017-10-31
  Description: During public health emergencies (PHEs) involving chemical, biological, radiological, or nuclear threats or emerging infectious diseases, medical countermeasures (MCMs) (e.g., drugs, vaccines, devices) may need to be dispensed or administered to…
• 

  CC Grand Rounds: Response to an Outbreak: Ebola Virus Monoclonal Antibody (mAb114) Rapid Clinical Development
  

  Tags Antibodies, Ebola, Immunology, Prophylaxis, R-Res&Pub, Research, Therapeutics, Vaccine Study
  Creator: NIH
  Subject: Research
  Item Type: Video
  Date Last Updated: 2019-03-19
  Description: This is a one hour lecture about the monoclonal antibody (mAb114) and ebola. It requires Flash plugin.

• Completing the Development of Ebola Vaccines: CURRENT STATUS, REMAINING CHALLENGES, AND RECOMMENDATIONS

  Tags Clinical Trial, Ebola, Ethics, Federal Research Partners, Prophylaxis, Public Health, R-Res&Pub, R-T&C, Research Design, Vaccine Study
  Creator: University of Minnesota, Center for Infectious Disease Research and Policy
  Subject: Treatment & Care
  Item Type: Publication
  Date Last Updated: 2017-01-17
  Description: In the third major report from the Wellcome Trust–CIDRAP Ebola Vaccine Team B reflects on progress to date and the remaining challenges faced.

• Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) for Ebola Virus Disease (EVD)

  Tags Ebola, Prophylaxis, R-T&C, Therapeutics
  Creator: WHO
  Subject: Treatment & Care
  Item Type: Guide
  Date Last Updated: 2018-08-27
  Description: A group of independent scientific experts were convened by the WHO for the purpose of updating the May 2018 statement on MEURI for Ebola virus disease (EVD) during the current outbreak, 27 August 2018. (1)
• 

  Ebola virus disease: an update on post-exposure prophylaxis.

  Tags Ebola, Immunology, Occupational Health, Prophylaxis, R-PM, R-Res&Pub
  Creator: Fischer, W. A. N., P. Vetter, D. G. Bausch, T. Burgess, R. T. Davey, Jr., R. Fowler, F. G. Hayden, P. B. Jahrling, A. C. Kalil, D. L. Mayers, A. K. Mehta, T. M. Uyeki and M. Jacobs
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2017-11-15
  Description: The massive outbreak of Ebola virus disease in west Africa between 2013 and 2016 resulted in intense efforts to evaluate the efficacy of several specific countermeasures developed through years of preclinical work, including the first clinical trials…

• Emory University Coursera Course – Ebola Virus Disease: An Evolving Epidemic

  Tags Communications, Diagnosis, Donning and Doffing, Ebola, Epidemic, Epidemiology, Ethics, Example, Immunology, Infection Prevention and Control, Lab, Laboratory, Laboratory Testing, Nursing, Outbreaks, Outcomes, Patient Care, Personal Protective Equipment (PPE), Prophylaxis, Public Health, Public Relations, Quarantine, R-PPE, Therapeutics, Virology
  Creator: Emory
  Subject: General
  Item Type: Online Course
  Date Last Updated: 2018-01-08
  Description: Ebola Virus Disease: An Evolving Epidemic - Emory University | Coursera

  Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.

• Flexible Clinical Trial Design Suitable for Emerging Disease Outbreaks

  Tags Clinical Trial, Ebola, Master Protocol, Prophylaxis, R-Res&Pub, Research Design, Special Pathogens, Therapeutics
  Creator: U.S. Food and Drug Administration (FDA)
  Subject: Research
  Item Type: Guide
  Date Last Updated: 2018-08-13
  Description: FDA CDER statisticians are designing trials with adaptive features to make clinical evaluation of new drug treatments more efficient and informative. (FDA)More information on the subject can be read here.

• Genomics and High-Consequence Infectious Diseases: A Scoping Review of Emerging Science and Potential Ethical Issues

  Tags Ethics, Legal, Prophylaxis, R-Res&Pub, Research, Therapeutics
  Creator: Angie M. Boyce and Brian T. Garibaldi.
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2019-02-19
  Description: Host genomic research on high-consequence infectious diseases is a growing area, but the ethical, legal, and social implications of such findings related to potential applications of the research have not yet been identified.